Cannabis Use Disorder Increasing Among Vets With Psychiatric Disorders
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Dec. 5, 2023 -- There is an increasing risk for cannabis use disorder among veterans with common psychiatric disorders, according to a study published online Nov. 29 in The American Journal of Psychiatry.
Ofir Livne, M.D., from the New York State Psychiatric Institute in New York City, and colleagues used Veterans Health Administration (VHA) electronic health records (2005 to 2019; 4.3 to 5.6 million) to assess whether trends in cannabis use disorder prevalence among VHA patients differ by psychiatric disorder.
The researchers observed greater increases in prevalence of cannabis use disorder diagnoses among patients with psychiatric disorders versus those without (differences in prevalence change, 1.91 and 0.34 percent for 2005 to 2014 and 2016 to 2019, respectively). The greatest disproportionate increases in cannabis use disorder prevalence among patients with psychiatric disorders were seen among those younger than 35 years between 2005 and 2014 and among those age 65 years and older between 2016 and 2019. The greatest increases in cannabis use disorder prevalences among patients with psychiatric disorders were seen in individuals with bipolar and psychotic-spectrum disorders.
"Greater public health and clinical efforts are needed to monitor, prevent, and treat cannabis use disorder in this population," the authors write.
One author disclosed ties to Syneos Health.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-06 06:37
Read more
- Long-Term Upadacitinib Use Feasible for Adolescents With Atopic Dermatitis
- Native Hawaiian and Pacific Islander Adults Have High CVD Mortality
- Sangamo Therapeutics Announces Alignment With FDA on Accelerated Approval Pathway for ST-920 in Fabry Disease With BLA Submission Expected in 2025
- AHA: GLP-1 RA, SGLT-2i Use Can Lower Risk for MI, Recurrent Stroke in Stroke Survivors
- Washington Becomes 6th State to Report Bird Flu in Humans
- Diagnostic Device Spots Malaria Without Need for Blood Sample
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions